Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.5c00197 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Vera M Masegosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain. Hauptthemen laut MEDLINE: Astrocytes, Amyotrophic Lateral Sclerosis, Motor Neurons, Frontotemporal Dementia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cure for MND Foundation, ALS Association, Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico.
Themen: Demenz
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) form a continuous spectrum of aggressive neurodegenerative diseases affecting primarily motoneurons (MNs) and cortical frontotemporal neurons. Noncell autonomous mechanisms contribute to ALS/FTD, wherein astrocytes release toxic factor(s) detrimental to MNs. Because of the multifactorial nature of ALS, single-pathway-focused therapies have limited effectiveness in improving ALS. Therefore, novel combinatorial therapies are currently being pursued. Here, we evaluated whether the simultaneous activation of two complementary targets, the voltage-gated potassium channels 7.2/3 (Kv7.2/3) and the mitochondrial translocator protein (TSPO), by a novel synthesized compound (GRT-X) is an effective neuroprotective treatment in ALS in vitro models. We exposed primary rat ventral spinal cord neuronal cultures and rat spinal cord organotypic cultures to astrocyte-conditioned medium derived from primary mouse ALS astrocytes expressing mutant human SOD1 (SOD1G93A-ACM) or from human-induced pluripotent stem cell (iPSC)-derived astrocytes carrying an ALS-causing mutation in SOD1 (SOD1D90A-ACM) or an ALS/FTD-causing mutation in TDP-43 (TDP43A90 V-ACM). We report that the diverse human and mouse ALS/FTD-ACMs compromise the MN viability. Remarkably, GRT-X led to consistent protection of MNs. Moreover, ALS/FTD-ACM increases oxidative stress levels, which are prevented with GRT-X treatment. Together, we show that the complementary activation of TSPO and Kv7.2/3 may offer a novel therapeutic strategy for ALS/FTD due to its capacity to protect MNs from noncell-autonomous toxicity induced by diseased astrocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain.
- Centro de Investigación Biomédica en Red (CIBER), Instituto de Salud Carlos III, Madrid 28029, Spain.
- Institute of Biomedical Sciences (ICB), Faculty of Medicine & Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370035, Chile.
- Grünenthal GmbH, Aachen 52099, Germany.
- Department of Neurology, University of Massachusetts Chan Medical School (UMMS), Worcester, Massachusetts 01655, United States.
- Millennium Nucleus of Neuroepigenetics and Plasticity (EpiNeuro), Santiago 8370035, Chile.
ORCID-Profile: Mireia Herrando-Grabulosa
Förderung
- Cure for MND Foundation
- ALS Association
- Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico
Zitieren
APA
Masegosa, V. M., Fritz, E., Corvalan, D., Rojas, F., Garcés, P., Navarro, X., Bloms-Funke, P., van Zundert, B., & Herrando-Grabulosa, M. (2025). Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00197
Vancouver
Masegosa VM, Fritz E, Corvalan D, Rojas F, Garcés P, Navarro X, et al. Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00197
BibTeX
@article{Masegosa2025,
author = {Masegosa, Vera M and Fritz, Elsa and Corvalan, Daniela and Rojas, Fabiola and Garcés, Polett and Navarro, Xavier and Bloms-Funke, Petra and van Zundert, Brigitte and Herrando-Grabulosa, Mireia},
title = {Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00197}
}
EUVIMED